Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in

Anna K. Nowak, W. Joost Lesterhuis, Peey‐Sei Kok, Chris Brown, Brett Hughes, Deme Karikios, Thomas John, Steven Kao, Connull Leslie, Alistair Cook, Nick Pavlakis, Karen Briscoe, Kenneth J. O’Byrne, Christos S. Karapetis, Wei‐Sen Lam, Ailsa Langford, Sonia Yip, Martin R. Stockler